Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2011

View Archived Issues

New muscarinic acetylcholine M1 receptor modulators claimed

Roche discloses new modulators of metabotropic glutamate mGlu5 receptor

Novel MK2 inhibitors synthesized at Merck & Co.

SHARP trial assesses simvastatin/ezetimibe combination in chronic kidney disease

One-pot approach creates semihollow microgel capsules for simultaneous multidrug delivery

Peptide P-13 ameliorates experimental otitis media

Dehydro-alpha-lapachone is natural antiangiogenic product that targets cell adhesion

Newron Pharmaceuticals submits IND for NW-3509 in schizophrenia

Biotron begins dosing final patient in phase IIa BIT-225 trial in genotype 1 hepatitis C

Sanofi and Regeneron report phase IIb data on sarilumab

Novel PKB inhibitors presented

Eisai to market and distribute Orion's Fareston and Eldepryl in China

Treatment begins in Cerulean Pharma's phase II CRLX-101 study in NSCLC

High-dose EPIAO approved in China to treat chemotherapy-associated anemia

GE Healthcare presents novel diagnostic imaging agents

AnaptysBio selects new antibody with potential to treat autoimmune diseases

FDA accepts sNDA for Dacogen in acute myeloid leukemia

Novadex presents new agents for HBV and HIV infections

Istituto Europeo di Oncologia patents new tubulin polymerization inhibitors

DSMB recommends discontinuation of Stallergenes' phase III trial of Actair

BioAlliance gives update on Livatag and Clonidine Lauriad

CMX-001 enters phase II trial in adenoviral disease and receives FDA fast track status

Teva completes acquisition of Taiyo Pharmaceutical

Consortium led by Ark Therapeutics receives E.U. Framework Programme 7 Grant

Watson Pharmaceuticals and Antares sign licensing agreement for Anturol gel in U.S. and Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...